Minutolo, Roberto http://orcid.org/0000-0001-5686-2089
Grandaliano, Giuseppe
Di Rienzo, Paolo
Snijder, Robert
Degli Esposti, Luca
Perrone, Valentina
Todorova, Lora
Funding for this research was provided by:
Astellas Pharma Inc
Università degli Studi della Campania Luigi Vanvitelli
Article History
Received: 8 February 2022
Accepted: 1 October 2022
First Online: 12 November 2022
Declarations
:
: RM has been a member of Advisory Boards for Amgen and Astellas, and invited speaker at meetings supported by Amgen, Astellas, and Vifor Pharma. GG has been an advisory board member for Astellas. PDR is an employee of Astellas Pharma Italia S.P.A. RS is an employee of Astellas Pharma Europe Ltd. LDE and VP are employees of CliCon Srl, an independent health, economics, and outcomes research company. The agreement signed by Clicon Srl and Astellas Pharma Inc. does not create any entityship, joint venture, or any similar relationship between parties. LT is an employee of Astellas Pharma Europe Ltd.
: Ethics Committees that approved the study: Comitato Etico Interaziendale (Vercelli), Comitato Etico Interprovinciale Area 1, Comitato Etico Lazio 2, Comitato Etico per le province di L'Aquila e Teramo, and Comitato Etico Unico Regionale del Friuli Venezia Giulia.
: These data were presented in part as a mini-oral presentation at the 58th European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Annual Congress, 5–8 June 2021, Berlin, Germany.